1436387-77-7

Basic information

• Product Name: N-((7-amino-8-benzyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-1-cyclopropylmethanesulfonamide
• Synonyms: N-((7-amino-8-benzyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-1-cyclopropylmethanesulfonamide
• CAS NO: 1436387-77-7
• Molecular Weight: 384.543
• Mol File: 1436387-77-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: N-((7-amino-8-benzyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-1-cyclopropylmethanesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-((7-amino-8-benzyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-1-cyclopropylmethanesulfonamide(1436387-77-7)
• EPA Substance Registry System: N-((7-amino-8-benzyl-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-1-cyclopropylmethanesulfonamide(1436387-77-7)

Safety Data

• Hazardous Substances Data: 1436387-77-7(Hazardous Substances Data)

Upstream product

• 1436387-74-4 tert-butyl 1-benzyl-7-((cyclopropylmethylsulfonamido)methyl)-1,2,3,4-tetrahydronaphthalen-2-ylcarbamate 
• 1240297-59-9 tert-Butyl 7-(aminomethyl)-1-benzyl-1,2,3,4-tetrahydronaphthalen-2-ylcarbamate 
• 1240298-06-9 tert-butyl 1-benzyl-7-cyano-1,2,3,4-tetrahydronaphthalen-2-ylcarbamate 
• 1436387-71-1 8-benzyl-7-(tert-butoxycarbonylamino)-5,6,7,8-tetrahydronaphthalen-2-yl trifluoromethanesulfonate 
• 1436387-70-0 tert-butyl 1-benzyl-7-hydroxy-1,2,3,4-tetrahydronaphthalen-2-ylcarbamate 
• 1436387-69-7 7-amino-8-benzyl-5,6,7,8-tetrahydronaphthalen-2-ol 
• 1436461-78-7 1-benzyl-7-methoxy-1,2,3,4-tetrahydronaphthalen-2-amine 

Downstream Products

• 1436387-60-8 N-((8-benzyl-7-(3-cyanooxetan-3-ylamino)-5,6,7,8-tetrahydronaphthalen-2-yl)methyl)-1-cyclopropylmethanesulfonamide 

Relevant articles and documents

N-SUBSTITUTED AMINOBENZOCYCLOHEPTENE, AMINOTETRALINE, AMINOINDANE AND PHENALKYLAMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY

The present invention relates to N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives of the formula (I), (II), (III) or (IV) or a physiologically tolerated salt thereof.The invention relates to pharmaceutical compositions comprising such N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, and the use of such N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives for therapeutic purposes. The N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives are GlyT1 inhibitors.